Farmacogenómica del Cáncer ; Pharmacogenomic of cancer
Gedelcan
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (7)
2023
-
Diverticulitis with abscess formation: Outcomes of non-operative management and nomogram for predicting emergency surgery: The Diplicab Study Collaborative Group
Surgery (United States), Vol. 174, Núm. 3, pp. 492-501
-
Risk factors for anastomotic leakage and postoperative outcomes after total and subtotal colectomy: A nationwide retrospective cohort study (RIALTCOT Study Collaborative Group)
Colorectal Disease, Vol. 25, Núm. 3, pp. 420-430
2021
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
2020
-
Complete loss of epcam immunoexpression identifies epcam deletion carriers in msh2negative colorectal neoplasia
Cancers, Vol. 12, Núm. 10, pp. 1-20
2003
-
Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer
International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790
1996
-
Single-dose cefminox versus triple-dose cefoxitin as antimicrobial prophylaxis in surgical treatment of patients with colorectal cancer
Current Therapeutic Research - Clinical and Experimental, Vol. 57, Núm. 7, pp. 559-565